Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the answer cohort study

HIGHLIGHTS

• who: Kosuke Ebina from the Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Osaka, Japan have published the Article: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study, in the Journal: (JOURNAL)
• what: The aim of this study is to evaluate the retention rates and reasons for discontinuation for seven biological disease-modifying antirheumatic drugs (bDMARDs) in a real-world setting of patients with rheumatoid arthritis (RA).
• how: The authors conducted a study to investigate the maintenance of bDMARD-free . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.